Bausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of “Hold” by Brokerages

Bausch + Lomb Co. (NYSE:BLCO) has received a consensus rating of “Hold” from the twelve analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $15.50.

A number of equities analysts have issued reports on the company. Morgan Stanley reduced their target price on Bausch + Lomb from $18.00 to $12.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. HC Wainwright reduced their price objective on shares of Bausch + Lomb from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Bank of America lowered their price target on Bausch + Lomb from $18.00 to $17.00 and set an “underperform” rating for the company in a report on Thursday, February 20th. Evercore ISI dropped their price objective on shares of Bausch + Lomb from $19.00 to $15.50 and set an “outperform” rating on the stock in a report on Thursday, May 1st. Finally, Royal Bank of Canada cut their target price on Bausch + Lomb from $18.00 to $17.00 and set an “outperform” rating on the stock in a research note on Friday, April 4th.

Insider Buying and Selling

In other Bausch + Lomb news, CEO Brent L. Saunders bought 22,000 shares of Bausch + Lomb stock in a transaction dated Thursday, May 22nd. The shares were purchased at an average cost of $11.28 per share, with a total value of $248,160.00. Following the completion of the purchase, the chief executive officer now owns 719,156 shares of the company’s stock, valued at approximately $8,112,079.68. This represents a 3.16% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.76% of the stock is owned by corporate insiders.

Institutional Trading of Bausch + Lomb

Large investors have recently added to or reduced their stakes in the stock. Deutsche Bank AG purchased a new position in shares of Bausch + Lomb during the 1st quarter worth approximately $50,750,000. Alberta Investment Management Corp grew its stake in Bausch + Lomb by 8.6% in the first quarter. Alberta Investment Management Corp now owns 3,266,193 shares of the company’s stock worth $47,360,000 after purchasing an additional 258,000 shares during the period. Whitebox Advisors LLC raised its holdings in Bausch + Lomb by 16.1% in the fourth quarter. Whitebox Advisors LLC now owns 1,443,101 shares of the company’s stock worth $26,062,000 after purchasing an additional 199,856 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Bausch + Lomb by 51.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,218,431 shares of the company’s stock worth $21,996,000 after purchasing an additional 414,138 shares in the last quarter. Finally, King Street Capital Management L.P. lifted its position in Bausch + Lomb by 55.2% during the fourth quarter. King Street Capital Management L.P. now owns 1,136,321 shares of the company’s stock valued at $20,522,000 after buying an additional 404,256 shares during the period. Institutional investors own 11.07% of the company’s stock.

Bausch + Lomb Trading Up 0.5%

BLCO opened at $11.51 on Wednesday. The firm has a 50 day simple moving average of $12.08 and a 200 day simple moving average of $15.56. Bausch + Lomb has a fifty-two week low of $10.45 and a fifty-two week high of $21.69. The company has a market cap of $4.07 billion, a price-to-earnings ratio of -12.64, a price-to-earnings-growth ratio of 0.85 and a beta of 0.58. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.60 and a quick ratio of 1.01.

Bausch + Lomb (NYSE:BLCO) last released its earnings results on Wednesday, April 30th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.10). The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. Bausch + Lomb had a positive return on equity of 3.35% and a negative net margin of 6.62%. Bausch + Lomb’s revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.07 EPS. On average, sell-side analysts anticipate that Bausch + Lomb will post 0.74 earnings per share for the current year.

Bausch + Lomb Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.